Total Payments
$102,390
2024 Payments
$203.15
Companies
16
Transactions
225
Payment Breakdown by Category
Other$58,538 (57.2%)
Travel$18,671 (18.2%)
Consulting$17,413 (17.0%)
Food & Beverage$6,469 (6.3%)
Education$1,300 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,900 | 25 | 49.7% |
| Travel and Lodging | $18,671 | 76 | 18.2% |
| Consulting Fee | $17,413 | 4 | 17.0% |
| Honoraria | $6,638 | 4 | 6.5% |
| Food and Beverage | $6,469 | 114 | 6.3% |
| Education | $1,300 | 1 | 1.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,000 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $43,542 | 66 | $0 (2020) |
| UCB, Inc. | $18,739 | 29 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $18,075 | 34 | $0 (2018) |
| Lundbeck LLC | $8,784 | 22 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $6,531 | 17 | $0 (2019) |
| LivaNova USA, Inc. | $2,194 | 9 | $0 (2018) |
| UCB SA | $1,308 | 8 | $0 (2018) |
| Medtronic USA, Inc. | $808.21 | 7 | $0 (2019) |
| NEUROPACE, INC. | $691.92 | 6 | $0 (2017) |
| Cyberonics, Inc. | $507.22 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.15 | 3 | SK Life Science, Inc. ($103.15) |
| 2023 | $183.72 | 2 | Azurity Pharmaceuticals, Inc. ($107.57) |
| 2022 | $37.46 | 2 | ABBVIE INC. ($37.46) |
| 2021 | $156.32 | 9 | AbbVie Inc. ($156.32) |
| 2020 | $293.83 | 8 | Allergan, Inc. ($235.40) |
| 2019 | $1,135 | 11 | Medtronic USA, Inc. ($808.21) |
| 2018 | $40,845 | 68 | Eisai Inc. ($23,293) |
| 2017 | $59,536 | 122 | Eisai Inc. ($20,229) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $71.12 | General |
| 04/15/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.03 | General |
| 04/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/03/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $76.15 | General |
| 04/25/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | In-kind items and services | $107.57 | General |
| Category: Sleep | ||||||
| 04/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: Neurology | ||||||
| 11/17/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $39.14 | General |
| Category: Neurology | ||||||
| 01/31/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Travel and Lodging | In-kind items and services | $290.00 | General |
| Category: Deep Brain Neurostimulation | ||||||
About Dr. David Ko, M.D
Dr. David Ko, M.D is a Epilepsy healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932143963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ko, M.D has received a total of $102,390 in payments from pharmaceutical and medical device companies, with $203.15 received in 2024. These payments were reported across 225 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,900).
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Clinical Neurophysiology
- Location Loma Linda, CA
- Active Since 06/16/2006
- Last Updated 03/19/2025
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1932143963
Products in Payments
- Fycompa (Drug) $43,522
- OXTELLAR XR (Drug) $18,075
- Vimpat (Drug) $9,213
- ONFI (Drug) $8,659
- APTIOM (Drug) $6,531
- Briviact (Drug) $4,588
- VNS Therapy (Device) $2,701
- ACTIVA (Device) $808.21
- RNS System (Device) $691.92
- UBRELVY (Drug) $570.97
- VRAYLAR (Drug) $126.45
- Horizant (Drug) $107.57
- QUTENZA (Drug) $100.00
- Dayvigo (Drug) $19.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.